Pittsburgh Fourth annual gi cancer summit

Platinum Sponsors: Amgen, AstraZeneca.
Gold Sponsors: Cogent Biosciences, Exelixis, Jazz Pharmaceuticals, Pfizer, Revolution Medicines.
Silver Sponsor: Takeda.
Bronze Sponsors: Bayer, BeOne Medicines, Bristol Myers Squibb, Caris Life Sciences, Exact Sciences is now Abbott, Ipsen, Merck, Natera, Novartis, Taiho Oncology, TerSera Therapeutics.

ACCREDITATION INFORMATION
This activity is jointly provided by Your CE Source and the Philips Group Oncology Communications, Inc.

Educational Objectives
After completing this activity, the participant should be able to:

1. Discuss strategies for the management of esophageal and gastric cancers, including endoscopic versus surgical approaches, perioperative immunotherapy, targeted therapy, biomarkers, and mechanisms of resistance.

2. Review emerging approaches in colorectal cancer care, including ctDNA-based minimal residual disease assessment, hepatic artery infusion pumps, immunotherapy in MSS disease, precision oncology, and total neoadjuvant therapy for rectal cancer.

3. Describe the clinical implications of KRAS-directed advances in gastrointestinal cancers and their role in transforming historically undruggable targets into actionable treatment strategies.

4. Explain recent advances in pancreatic cancer detection, resectability assessment, tumor microenvironment modulation, and emerging therapeutic targets.

5. Evaluate PRRT sequencing strategies, targeted therapy, and emerging treatment options for neuroendocrine tumors.

6. Review current and emerging approaches for hepatobiliary cancers, including locoregional therapy, immunotherapy sequencing, biology-driven treatment selection, and expanding precision oncology targets in cholangiocarcinoma.

Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Your CE Source and the Phillips Group Oncology Communications, Inc. Your CE Source is accredited by the ACCME to provide continuing medical education for physicians.

Your CE Source designates this live activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Accreditation Statement
Your CE Source is an approved provider of continuing nursing education by the California Board of Registered Nursing. Provider approved by California Board of Registered Nursing, Provider #16031 for 6 contact hours.

MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclaimer Statement
The content, views and opinions presented in this educational activity are those of the faculty/authors and do not necessarily reflect those of Your CE Source, the Phillips Group Oncology Communications, Inc. The faculty/authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

The prospectus can be found HERE.
The W9 can be here HERE.

1. What types of CME events do you offer?
   We offer a range of live and virtual Continuing Medical Education (CME) events
   designed to provide the latest developments in oncology research and practice.
2. How can I register for an event?
   You can register for our events through our website by visiting the event-specific
   page.
3. What topics do your events cover?
   Our events cover various oncology-related topics, such as gastrointestinal
   cancers, lymphomas, myeloma, and advancements in cancer treatment. Each
   event has a detailed agenda outlining session topics and speakers.
4. Are your events accredited for CME, CNE, or pharmacy credits?
   Yes, our events are accredited through Your CE Source and offer CME, CNE,
   and Pharmacy credits. The specific number of credits will be listed in the event
   details.
5. How can I claim my CME credits?
   A poster outside of the general session at each meeting will show how to claim
   credit. Additionally, we will send you instructions on claiming your credit after the
   meeting.
6. Will I be able to reserve a room at the conference hotel?
   Yes, we will provide a unique booking link on the specific meeting’s homepage.
7. Where can I access the presentation slides?
   We will send out a link before each meeting to access PDF versions of the slides.
   Slides will become available during each event session, not ahead of time.
8. What is the meeting dress code?
   We ask that attendees dress in business casual attire for our in-person events.
9. Who can I contact for additional questions?
   For any questions or concerns, please reach out to us via email at
   info@pgoncology.com or use the contact form on our website.